These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18789912)

  • 1. Identification of a xylosyltransferase II gene haplotype marker for diabetic nephropathy in type 1 diabetes.
    Hendig D; Tarnow L; Kuhn J; Kleesiek K; Götting C
    Clin Chim Acta; 2008 Dec; 398(1-2):90-4. PubMed ID: 18789912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes.
    Schön S; Prante C; Bahr C; Tarnow L; Kuhn J; Kleesiek K; Götting C
    Diabetes Care; 2006 Oct; 29(10):2295-9. PubMed ID: 17003309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy.
    Schön S; Prante C; Müller S; Schöttler M; Tarnow L; Kuhn J; Kleesiek K; Götting C
    Kidney Int; 2005 Oct; 68(4):1483-90. PubMed ID: 16164625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel sequence variants in the human xylosyltransferase I gene and their role in diabetic nephropathy.
    Bahr C; Schön S; Kuhn J; Groop PH; Parkkonen M; Wessman M; Kleesiek K; Götting C
    Diabet Med; 2006 Jun; 23(6):681-4. PubMed ID: 16759312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common polymorphisms of the PAI1 gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes.
    Martin RJ; Savage DA; Patterson CC; Brady HR; Maxwell AP
    Diabet Med; 2007 Mar; 24(3):259-65. PubMed ID: 17263760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course.
    Schön S; Schulz V; Prante C; Hendig D; Szliska C; Kuhn J; Kleesiek K; Götting C
    J Med Genet; 2006 Sep; 43(9):745-9. PubMed ID: 16571645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xylosyltransferase gene variants and their role in essential hypertension.
    Pönighaus C; Speirs HJ; Morris BJ; Kuhn J; Kleesiek K; Götting C
    Am J Hypertens; 2009 Apr; 22(4):432-6. PubMed ID: 19197251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The xylosyltransferase Iota gene polymorphism c.343G>T (p.A115S) is associated with decreased serum glycosaminoglycan levels.
    Ambrosius M; Kleesiek K; Götting C
    Clin Biochem; 2009 Jan; 42(1-2):1-4. PubMed ID: 19014925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xylosyltransferase I variants and their impact on abdominal aortic aneurysms.
    Götting C; Prante C; Schillinger M; Exner M; Domanovits H; Raith M; Kuhn J; Kleesiek K
    Clin Chim Acta; 2008 May; 391(1-2):41-5. PubMed ID: 18294457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus].
    Iakunina NIu; Shestakova MV; Voron'ko OE; Vikulova OK; Sevost'ianov KV; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV
    Genetika; 2005 Jul; 41(7):931-7. PubMed ID: 16152798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 7q35 and susceptibility to diabetic microvascular complications.
    Patel A; Hibberd ML; Millward BA; Demaine AG
    J Diabetes Complications; 1996; 10(2):62-7. PubMed ID: 8777332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A search for association between the polymorphic markers of PON1 and PON2 genes and diabetic nephropathy in patients with type I diabetes mellitus].
    Voron'ko OE; Iakunina NIu; Shestakova MV; Zotova EV; Chugunova EV; Shamkhalova MSh; Vikulova OK; Debabov VG; Dedov VG; Nosikov VV
    Genetika; 2005 Jun; 41(6):844-9. PubMed ID: 16080611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening.
    Nair S; Phillips AO; Norton N; Spurlock G; Williams HJ; Craig KJ; Williams JD; Williams NM; Bowen T
    J Nephrol; 2008; 21(3):400-5. PubMed ID: 18587729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
    Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of polymorphous markers Pro72Arg and C(-594)CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow].
    Spitsina EV; Iakunina NIu; Chudakova DA; Nikitin AG; Svetlova GN; Soluianova TN; Strokov IA; Nosikov VV
    Mol Biol (Mosk); 2007; 41(6):989-93. PubMed ID: 18318116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
    Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Search for the association of polymorphic markers for genes coding for antioxidant defense enzymes, with development of diabetic polyneuropathies in patients with type 1 diabetes mellitus].
    Zotova EV; Savost'ianov KV; Chistiakov DA; Bursa TR; Galeev IV; Strokov IA; Nosikov VV
    Mol Biol (Mosk); 2004; 38(2):244-9. PubMed ID: 15125229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of human xylosyltransferase II promoter single nucleotide variants.
    Faust I; Böker KO; Eirich C; Akkermann D; Kuhn J; Knabbe C; Hendig D
    Biochem Biophys Res Commun; 2015 Mar; 458(4):901-7. PubMed ID: 25704086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between (AC)n dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene and diabetic nephropathy: a meta-analysis.
    Xu M; Chen X; Yan L; Cheng H; Chen W
    J Mol Endocrinol; 2008 May; 40(5):243-51. PubMed ID: 18434430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.